Dr. Renaghan is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
199 Spotnap Rd
Ste 1
Charlottesville, VA 22911Phone+1 434-971-8888Fax+1 434-296-6734
Education & Training
- New York Presbyterian Hospital (Cornell Campus)Residency, Internal Medicine, 2012 - 2015
- University of Virginia School of MedicineClass of 2012
Certifications & Licensure
- VA State Medical License 2017 - 2026
- NY State Medical License 2016 - 2018
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Nephrology
Awards, Honors, & Recognition
- Inductee Alpha Omega Alpha Honor Medical Society, 2011
Publications & Presentations
PubMed
- 6 citationsAcute kidney injury in patients receiving pembrolizumab combination therapy versus pembrolizumab monotherapy for advanced lung cancer.Shruti Gupta, Ian A Strohbehn, Qiyu Wang, Paul E Hanna, Rituvanthikaa Seethapathy
Kidney International. 2022-10-01 - 13 citationsShorter versus longer corticosteroid duration and recurrent immune checkpoint inhibitor-associated AKI.Shruti Gupta, Clara Garcia-Carro, Jason M Prosek, Ilya Glezerman, Sandra M Herrmann
Journal for Immunotherapy of Cancer. 2022-09-01 - Minimal Change Disease Secondary to Graft-versus-Host Disease after Allogeneic Hematopoietic Cell Transplant for Myelodysplastic Syndrome.Omar Elghawy, John S Wang, Alexander C Hafey, Amanda D Renaghan, Rachel M Whitehair
Case Reports in Nephrology and Dialysis. 2022-03-14
Authored Content
- Acute Kidney Injury and CKD Associated with Hematopoietic Stem Cell TransplantationFebruary 2020
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: